Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics.
Introduction
Emerald Health Therapeutics (OTCQX:EMHTF) only had $3 million cash left at the end of Q2. The company managed to get $25 million from issuing convertible debentures but $10 million of that will go straight into paying for its Quebec acquisition. We think the company is likely going to need to raise additional capital again in order to fund remaining facility buildouts and fulfilling its commitment to the Pure Sunfarms JV.